PMC:7396557 / 11080-11281
Annnotations
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T60 | 98-106 | SP_7 | denotes | COVID-19 |
| T93839 | 98-106 | SP_7 | denotes | COVID-19 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T60 | 98-106 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T83938 | 46-49 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T99 | 7-39 | Sentence | denotes | Recommended Therapeutic Regimens |
| T100 | 40-165 | Sentence | denotes | HXZQC has been recommended in 20 therapeutic regimens for COVID-19 in China (see detailed information in Tables 1 and 2 ). |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 147 | 98-106 | Disease | denotes | COVID-19 | MESH:C000657245 |